Muvalaplin in Phase II angekommen | PZ – Pharmazeutische Zeitung

2024-09-22 09:26:48 | on phase

You are leaving and open the following URL" of about "on phase" news

news.google.com/rss/articles/CBMiUGh0dHBzOi8vd3d3LnBoYXJtYXpldXRpc2NoZS16ZWl0dW5nLmRlL211dmFsYXBsaW4taW4tcGhhc2UtaWktYW5nZWtvbW1lbi0xNDE5ODYv0gEA?oc=5

Continue Opne >

on phase: Muvalaplin in Phase II angekommen | PZ – Pharmazeutische Zeitung

More on phase news:

2024-07-11 07:00 First Patient Dosed in Phase I Clinical Trial of YOLT-201 - 팜뉴스
2024-06-18 07:00 ABL Bio's partner company, Compass Therapeutics, releases phase 2 and 3 clinical research findings on ABL001 for biliary tract cancer - 더바이오
2024-03-28 07:00 HLB “expands the value of rivoceranib” - IT조선
2024-07-11 07:00 Kolon TissueGene completes patient dosing in phase 3 osteoarthritis gene therapy study - KBR
2023-12-01 08:00 280Bio doses first patient in Phase I clinical trial of TEB-17231, an oral pan-RAS inhibitor in patients with advanced cancers harboring mutations in KRAS, HRAS, or NRAS - 팜뉴스
2023-05-11 07:00 Oncocross Completes Phase 1 Global Clinical Trial of OC514, Treatment for Sarcopenia - 뉴스와이어
2024-06-28 07:00 Hyundai Pharm showcases diabetes drug efficacy in phase 2 trial at ADA meet in US - KBR
2024-01-02 08:00 Innovent Dosed First Participant in Phase 3 Clinical Study (GLORY-2) of Mazdutide (IBI362) Higher Dose 9 mg in Chinese Adults with Obesity - 팜뉴스
2024-08-07 07:00 Huonslab scores IND nod for clinical trial of recombinant human hyaluronidase - KBR

2024-08-26 07:00 GI Innovation, MSD to evaluate new immunotherapy+Keytruda in resistant cancers in phase 2 study - KBR
2023-06-01 07:00 Aravax doses first patient in Phase 2 peanut allergy clinical trials - 팜뉴스
2022-08-18 07:00 CG Pharmaceuticals Announces First Patient Dosed in Phase 1b/2 Study Evaluating Ivaltinostat for the Treatment of Pancreatic Adenocarcinoma - 팜뉴스
2023-08-22 07:00 Kintor Pharma Announces Completion of Patient Enrollment in Phase II Clinical Trial of GT20029 for Treatment of Androgenetic Alopecia in China - 팜뉴스
2023-04-14 07:00 Zenshine Pharmaceuticals' ZX-7101A Met the Primary Endpoint of the Phase 2 Study for the Treatment of Acute Uncomplicated Influenza in Adults - 팜뉴스
2022-11-30 08:00 Kira Pharmaceuticals Announces First Cohort of Patients Dosed in Phase 2 Study of KP104 in Paroxysmal Nocturnal Hemoglobinuria (PNH) - 팜뉴스
2022-09-27 07:00 Neurophth announces first patient dosed in Phase III clinical trial for the gene therapy treatment of LHON - 팜뉴스
2022-06-13 07:00 Curocell announced impressive CR rate in Phase 1 study with anbal-cel, the next generation CD19 CAR-T integrated OVIS™ platform - 팜뉴스
2022-11-15 08:00 Reistone Biopharma's oral Ivarmacitinib Meets Primary Endpoint in Phase III Study for Atopic Dermatitis - 팜뉴스
2024-02-19 08:00 Neurophth Announces Completion of Patient Enrollment for Opvika® Phase I/II Clinical Trial in the U.S. - 팜뉴스

2022-09-08 07:00 InxMed Announces First Patient Dosed in Phase 2 Pivotal Study of IN10018 In Patients with Platinum-Resistant Recurrent Ovarian Cancer - 팜뉴스
2023-03-30 07:00 DxVx Co., Ltd.'s affiliated company, Oxford Vacmedix (OVM) successfully completed Phase 1a in clinical trial of novel cancer vaccine OVM-200 - 팜뉴스
2023-07-12 07:00 Sciwind Biosciences Announces Publication of Discovery, Preclinical, and Phase 1 Clinical Trial Results of Ecnoglutide (XW003) in Molecular Metabolism - 팜뉴스
2024-08-14 07:00 Celltrion Receives U.S. Phase 3 IND Approval for Cosentyx Biosimilar 'CT-P55' - Korea IT Times
2020-03-29 07:00 “We take responsibility for all participants in phase 3 clinical trial to the end.” - 헬스경향
2022-09-05 07:00 Aston Sci. Receives IND Approval from U.S. FDA for Phase 2 Clinical Trial of the Therapeutic Cancer Vaccine AST-301 in Patients with HER2 1+/2+ Breast Cancer - 팜뉴스
2022-07-22 07:00 Bukwang Pharmaceutical succeeds in phase 3 clinical trial for schizophrenia treatment ‘Lurasidone’ - Korea IT Times
2022-07-25 07:00 Bukwang Pharmaceutical confirms 'effectiveness' in phase 3 clinical trial of schizophrenia treatment - 인포스탁데일리
2023-04-18 07:00 VENTURE GLOBAL ANNOUNCES SUCCESSFUL ROOF RAISING OF SECOND STORAGE TANK AT PLAQUEMINES LNG - KIPOST
2021-11-16 08:00 Kim Jong-un Inspects the Samjiyon Development Project on Site: First Press Coverage of Public Schedule in 35 Days - 경향신문

2019-03-05 08:00 Anterogen, diabetic foot ulcer patch “encouraging efficacy in phase 2 trial” - 바이오스펙테이터
2023-11-01 07:00 'Alzheimer's pill AR1001 showed promising results in phase 2 trial' - KBR
2021-09-15 07:00 신소재 데이터 위한 인공지능 훈련 방법론 개발 - 카이스트 신문
2019-03-25 07:00 HanAll starts Phase 3 clinical trial of HL036, a new drug for dry eye, in the U.S. - 바이오스펙테이터
2022-12-21 08:00 GSK Korea launches Shingrix, a shingles vaccine with 97% efficacy - 의약뉴스
2023-09-05 07:00 ABL Bio has entered the PD-L1x4-1BB BsAb competition with promising Phase 1 interim results - 바이오스펙테이터
2022-11-21 08:00 Jiangsu Recbio Technology Co., Ltd. Increases Production For The First Phase Of Manufacturing Facility With A Maximum Annual Output Of 20 Million Doses Of Recombinant HPV 9-Valent Vaccine - 팜뉴스
2023-10-12 07:00 HanAll Biopharma, Daewoong Pharmaceutical and NurrOn Pharmaceuticals Initiate First-in-Human Phase 1 Clinical Study of HL192 - 팜뉴스
2023-02-20 08:00 Bridge Bio fails to prove ulcerative colitis drug’s efficacy in phase 2a trial - KBR
2022-04-22 07:00 Daewoong’s Nabota, the world’s first successful square jaw slimming clinical trial in Phase 3 - Korea IT Times

2019-10-11 07:00 Avixgen secured 4 Clinical Pipelines … “Expansion of AIDS Clinical Trial to USA” - 바이오스펙테이터
2014-02-23 08:00 Floating blimp bumper buses may arrive in 2028 - koreatimes
2015-07-02 07:00 Doosan Heavy Wins 2 Water Treatment Projects in Oman and Britain - Korea IT Times
2024-05-13 07:00 Chong Kun Dang accelerates developing new hair loss treatment ‘CKD-843’ - KBR
2022-02-22 08:00 Eyegene scores nod for mRNA vaccine study in Australia - KBR
2022-08-10 07:00 Biogen gives up releasing Alzheimer’s drug Aduhelm in Korea - KBR
2023-09-27 07:00 Bridge Biotherapeutics discards NSCLC drug candidate BBT-176 - KBR
2022-07-11 07:00 Daiichi Sankyo Korea wins expanded indication for neuropathic pain treatment Taleaje - KBR
2022-09-23 07:00 MSD’s Keytruda OKed for 1st-line treatment for cervical cancer - KBR
2021-09-09 07:00 Regulators OKs Novartis’ inherited retinal dystrophy treatment - KBR

2021-03-04 08:00 Il-Yang’s leukemia drug fails to prove efficacy as Covid-19 therapy - KBR
2019-03-22 07:00 Eubiologics gets nod to test botulinum toxin in phase-1 study - KBR
2022-11-10 08:00 GSK will conduct phase 3 trial of Bepirovirsen despite drops in efficacy - KBR
2019-08-22 07:00 SK Biopharmaceutical’s sleepiness drug initially aimed to treat depression - KBR

About on phase

2024-09-22 from kr

Warning: file_get_contents(aCache/search/kr/on phase): Failed to open stream: Permission denied in /var/www/hoodb/function.php on line 340

on phase, Muvalaplin in Phase II angekommen | PZ – Pharmazeutische Zeitung 2022 on phase

Muvalaplin in Phase II angekommen | PZ – Pharmazeutische Zeitung

Choose Your Country or Region

Muvalaplin in Phase II angekommen | PZ – Pharmazeutische Zeitung

Copyright © 2020-2021 hoodb.com. All Rights Reserved.